Levetiracetam May Improve Survival in Patients With Glioblastoma
Adding levetiracetam to standard of care led to better survival overall, but certain patient subgroups may derive a greater benefit, according to a preprint study that has not yet been peer-reviewed.
First Look
source https://www.medscape.com/viewarticle/966253?src=rss
First Look
source https://www.medscape.com/viewarticle/966253?src=rss
Comments
Post a Comment